The Cell Factory develops highest quality therapeutic tools for affordable regenerative medicine.

The Cell Factory is a biotech company focused on development, clinical translation and commercialization of the advanced extracellular vesicles biologic drugs and autologous stem cell therapies.


Company overview

The Cell Factory is a full subsidiary business unit of Esperite Group (Euronext: ESP), listed at Euronext Amsterdam and Paris. Esperite is a leading international company in biobanking, regenerative and predictive medicine since 2000.


The Cell Factory activity focuses on two pillars:

  • Therapeutics development: Investigation and development of new therapeutic products in niche applications in regenerative medicine: “of-the-shelf” advanced biologics (extracellular vesicles) and autologous stem cells.
  • Technology development: Expanding of the technology platform, infrastructure, know-how and IP portfolio for manufacturing of extracellular vesicles, exosomes, and stem cell products for applications in regenerative medicine and diagnostics.

Allogenic exosomes therapies

Allogenic “off-the-shelf” MSC-derived extracellular vesicles and exosomes used as immunomodulatory drugs and inhibitors of acute and chronic inflammation in treatment of unmet medical needs i.e. Drug-resistant Epilepsy and Crohn’s disease.


Autologous stem cells therapies

Autologous stem cells derived from cryopreserved cord-blood, and cord tissue and adipose tissue for applications in personalized regenerative medicine i.e. Cerebral Palsy.

Get in touch

If you have a question you can enter it here and one of our members of staff will get back to you…